drugset / Trial / NCT06857370
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a randomized, blinded, peer-controlled study. There will be 3 treatment groups, screened subjects were randomized in a 1:1:1 ratio to receive three batches of the DTcP trial vaccine, and completed the primary immunization according to the procedure of one dose each at 2, 4, and 6 months of age.
Timeline
- Start
- 2025-03-23
- Primary completion
- 2026-01
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Vaccine | 0.5 ml | — |
Indications
No indication recorded.